ACET
Price
$7.83
Change
-$0.28 (-3.45%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
82.08M
Intraday BUY SELL Signals
HUMA
Price
$1.41
Change
+$0.01 (+0.72%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
310.83M
75 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACET vs HUMA

Header iconACET vs HUMA Comparison
Open Charts ACET vs HUMABanner chart's image
ACET vs HUMA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACET vs. HUMA commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and HUMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (ACET: $8.11 vs. HUMA: $1.40)
Brand notoriety: ACET and HUMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 135% vs. HUMA: 139%
Market capitalization -- ACET: $82.08M vs. HUMA: $310.83M
ACET [@Biotechnology] is valued at $82.08M. HUMA’s [@Biotechnology] market capitalization is $310.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileHUMA’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • HUMA’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than HUMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 5 TA indicator(s) are bullish while HUMA’s TA Score has 6 bullish TA indicator(s).

  • ACET’s TA Score: 5 bullish, 4 bearish.
  • HUMA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, HUMA is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -2.64% price change this week, while HUMA (@Biotechnology) price change was +26.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

HUMA is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HUMA($311M) has a higher market cap than ACET($82.1M). HUMA YTD gains are higher at: 45.757 vs. ACET (-3.682). HUMA has higher annual earnings (EBITDA): -18.94M vs. ACET (-102.73M). ACET has more cash in the bank: 138M vs. HUMA (19.5M). ACET has less debt than HUMA: ACET (13.9M) vs HUMA (29.8M). HUMA has higher revenues than ACET: HUMA (1.57M) vs ACET (0).
ACETHUMAACET / HUMA
Capitalization82.1M311M26%
EBITDA-102.73M-18.94M542%
Gain YTD-3.68245.757-8%
P/E RatioN/AN/A-
Revenue01.57M-
Total Cash138M19.5M708%
Total Debt13.9M29.8M47%
FUNDAMENTALS RATINGS
ACET: Fundamental Ratings
ACET
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
24
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACETHUMA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signal:
Gain/Loss:
HUMA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECTMX17.11N/A
N/A
Eaton Vance Dividend Builder C
EPGAX25.75N/A
N/A
Fidelity Advisor Equity Growth A
PRKCX7.73N/A
N/A
PGIM Real Estate Income C
FSTLX38.51N/A
N/A
Federated Hermes MDT Large Cap Value R6
SNTFX22.48N/A
N/A
Steward Values Enhanced International R6

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with KURA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-7.63%
KURA - ACET
45%
Loosely correlated
-0.72%
OGI - ACET
41%
Loosely correlated
-3.54%
VIR - ACET
41%
Loosely correlated
-3.21%
RXRX - ACET
40%
Loosely correlated
-4.62%
TCRX - ACET
39%
Loosely correlated
-2.89%
More

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with ACET. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
-3.45%
ACET - HUMA
38%
Loosely correlated
-7.63%
RXRX - HUMA
37%
Loosely correlated
-4.62%
VKTX - HUMA
34%
Loosely correlated
-6.33%
BEAM - HUMA
34%
Loosely correlated
-7.00%
RGNX - HUMA
33%
Loosely correlated
-8.68%
More